Anavex Life Sciences
AVXL
59 hedge funds and large institutions have $29.7M invested in Anavex Life Sciences in 2016 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 20 increasing their positions, 11 reducing their positions, and 6 closing their positions.
117% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 6
82% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 11
79% more capital invested
Capital invested by funds: $16.6M → $29.7M (+$13.1M)
18.95% more ownership
Funds ownership: 0% → 18.95% (+19%)
11% more funds holding
Funds holding: 53 → 59 (+6)
92% less call options, than puts
Call options by funds: $491K | Put options by funds: $6.04M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PWAM
Park West Asset Management
San Francisco,
California
|
+$5.34M |
| 2 |
KCM
Knoll Capital Management
Miami,
Florida
|
+$2.58M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$739K |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$612K |
| 5 |
Morgan Stanley
New York
|
+$446K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
-$434K |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$129K |
| 3 |
Tudor Investment Corp
Stamford,
Connecticut
|
-$75K |
| 4 |
Millennium Management
New York
|
-$73K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$60.3K |
AVXL Hedge Fund Activity: Q4 2016 in Review
59 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in Anavex Life Sciences (AVXL) for Q4 2016, worth a combined $29.7M — up 79% from $16.6M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new AVXL positions and 6 closed out — a net gain of 7 holders — while 20 added to existing stakes and 11 trimmed.
The largest buyer was Park West Asset Management, opening a new position worth an estimated $5.34M. The largest seller was D.E. Shaw & Co, exiting entirely with an estimated $434K sold.
- 59 institutional investors held Anavex Life Sciences (AVXL) as of Q4 2016, up from 53 in Q3 2016.
- Funds reported $29.7M of Anavex Life Sciences stock for Q4 2016, up 79% quarter-over-quarter.
- 13 funds opened new Anavex Life Sciences positions in Q4 2016 and 6 closed out, a net change of +7 holders.
- The largest Anavex Life Sciences buyer in Q4 2016 was Park West Asset Management, an estimated $5.34M added.
- The largest Anavex Life Sciences seller in Q4 2016 was D.E. Shaw & Co, an estimated $434K sold.
Based on aggregated 13F filings for Q4 2016.